Researchers find more clues to causes of breast cancer

Publishing in the current issue of The Journal of Biological Chemistry , researchers at Moffitt Cancer Center in Tampa, Fla., have discovered additional mechanisms of “Akt” activation and suggest a component of that activation mechanism inhibitor of nuclear factor kappa-B kinase subunit epsilon could be targeted as a therapeutic intervention for treating cancer.

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google

, , , , , , , , , , , , ,